Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q24655964)
Watch
English
Multiple myeloma
scientific article
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Multiple myeloma
(English)
0 references
main subject
cell biology
0 references
author
Robert A Kyle
series ordinal
1
object named as
Robert A Kyle
0 references
S. Vincent Rajkumar
series ordinal
2
object named as
S Vincent Rajkumar
0 references
language of work or name
English
0 references
publication date
15 March 2008
0 references
published in
Blood
0 references
volume
111
0 references
issue
6
0 references
page(s)
2962-72
0 references
cites work
The nature of Bence-Jones proteins. Chemical similarities to polypetide chains of myeloma globulins and normal gamma-globulins
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
7 April 2017
Thalidomide is an inhibitor of angiogenesis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
7 April 2017
Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99-06): a randomised trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
7 April 2017
Melphalan, prednisone, and lenalidomide treatment for newly diagnosed myeloma: a report from the GIMEMA--Italian Multiple Myeloma Network
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
7 April 2017
The ubiquitin-proteasome proteolytic pathway
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
7 April 2017
Case of Mollities and Fragilitas Ossium, accompanied with urine strongly charged with animal matter
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Remarks on the Pathology of Mollities Ossium. With Cases
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
ELECTROPHORETIC PATTERNS OF NORMAL AND PATHOLOGICAL HUMAN BLOOD SERUM AND PLASMA.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: combination therapy improves time to progression
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
A comparison of allografting with autografting for newly diagnosed myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Prevalence of monoclonal gammopathy of undetermined significance
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
International staging system for multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Multiple myeloma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Incidence of multiple myeloma in Olmsted County, Minnesota: Trend over 6 decades
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Thalidomide: tragic past and promising future
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Treatment of plasma cell dyscrasias with thalidomide and its derivatives
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
THALIDOMIDE (N-PHTHALOYLGLUTAMIMIDE) IN THE TREATMENT OF ADVANCED CANCER.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
A phase 2 study of bortezomib in relapsed, refractory myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Multiple myeloma: an odyssey of discovery
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Antitumor activity of thalidomide in refractory multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Proteasome inhibitors: a novel class of potent and effective antitumor agents.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Tumor growth inhibition induced in a murine model of human Burkitt's lymphoma by a proteasome inhibitor.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Cation-sensitive neutral endopeptidase: isolation and specificity of the bovine pituitary enzyme
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Melphalan in multiple myeloma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
A controlled trial of urethane treatment in multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 September 2017
Treatment of newly diagnosed multiple myeloma based on Mayo Stratification of Myeloma and Risk-adapted Therapy (mSMART): consensus statement
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
30 May 2018
Electrophoresis of proteins on filter paper
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
30 May 2018
Inhibition of Rabbit Brain Prolyl Endopeptidase by N‐Benzyloxycarbonyl‐Prolyl‐Prolinal, a Transition State Aldehyde Inhibitor
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
30 May 2018
Response rate and survival in myeloma patients receiving prednisone alone.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
30 May 2018
Identical-twin (syngeneic) marrow transplantation for hematologic cancers.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
30 May 2018
VAD-based regimens as primary treatment for multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
30 May 2018
Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
30 May 2018
Urethane and stilbamidine in multiple myeloma report on two cases.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
AN ELECTROPHORETIC STUDY OF IMMUNE SERA AND PURIFIED ANTIBODY PREPARATIONS.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Prospective, randomized study of single compared with double autologous stem-cell transplantation for multiple myeloma: Bologna 96 clinical study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
A practical guide to defining high-risk myeloma for clinical trials, patient counseling and choice of therapy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Standard chemotherapy compared with high-dose chemoradiotherapy for multiple myeloma: final results of phase III US Intergroup Trial S9321.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
Single versus double autologous stem-cell transplantation for multiple myeloma.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue treatment? Results of a multicenter sequential randomized clinical trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2265446
retrieved
28 November 2018
[Clinical experiences with sarcolysin in neoplastic diseases]
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
High-dose intravenous melphalan for plasma-cell leukaemia and myeloma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Multiple myeloma treated with high dose intravenous melphalan
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Evaluation of new chemotherapeutic agents in the treatment of multiple myeloma. IV. L-Phenylalanine mustard (NSC-8806)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Prospective comparison of autologous stem cell transplantation followed by dose-reduced allograft (IFM99-03 trial) with tandem autologous stem cell transplantation (IFM99-04 trial) in high-risk de novo multiple myeloma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Studies on conditions associated with disturbed gamma globulin formation (gammopathies)
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Intermittent high-dose prednisone (NSC-10023) therapy for multiple myeloma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Combination chemotherapy of multiple myeloma with Alkeran, Cytoxan, vincristine, prednisone, and BCNU
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Treatment for multiple myeloma. Combination chemotherapy with different melphalan dose regimens
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
High-dose chemoradiotherapy and autologous bone marrow transplantation for resistant multiple myeloma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
DIRECT IMMUNOELECTROPHORESIS
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
CLINICAL EXPERIENCES WITH THALIDOMIDE IN PATIENTS WITH CANCER
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Multiple-myeloma proteins. III. The antigenic relationship of Bence Jones proteins to normal gammaglobulin and multiple-myeloma serum proteins
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Monoclonal gammopathy of undetermined significance. Natural history in 241 cases
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. Myeloma Trialists' Collaborative Group
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Bone marrow transplantation in multiple myeloma: report from the European Cooperative Group for Bone Marrow Transplantation
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
[Method permitting the combined study of the electrophoretic and the immunochemical properties of protein mixtures; application to blood serum]
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
Identical twin marrow transplantation in multiple myeloma
1 reference
stated in
PubMed
reference URL
https://pubmed.ncbi.nlm.nih.gov/18332230
retrieved
12 December 2020
based on heuristic
inferred from PubMed ID database lookup
THALIDOMIDE AND CONGENITAL ABNORMALITIES
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FBLOOD-2007-10-078022
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A new apparatus for electrophoretic analysis of colloidal mixtures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FBLOOD-2007-10-078022
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
On a New Substance Occurring in the Urine of a Patient with Mollities Ossium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1182%2FBLOOD-2007-10-078022
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1182/BLOOD-2007-10-078022
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
270572
OpenCitations bibliographic resource ID
270572
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
270572
PMC publication ID
2265446
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
270572
PubMed publication ID
18332230
1 reference
stated in
Consolidated OpenCitations Corpus – April 2017
OpenCitations bibliographic resource ID
270572
ResearchGate publication ID
5520484
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
